Position in LLY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$19,421,862
-$3,686,984 QoQ
Shares Held
21,116
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.73082023110437.ToString("F0")%
Shared 0.ToString("F0")%
None 1.2691797688956241.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FERGUSON WELLMAN CAPITAL MANAGEMENT, INC holds $467,957,783 across 9 Drug Manufacturers - General names. LLY ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
650,411 | $141,457,887 | |
| 2 | JNJ |
Johnson & Johnson
|
469,028 | $114,649,203 | |
| 3 | AMGN |
Amgen Inc
|
319,238 | $112,323,890 | |
| 4 | MRK |
Merck & Co., Inc.
|
385,956 | $46,426,647 | |
| 5 | NVS |
Novartis AG
|
182,356 | $27,854,879 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
21,116 | $19,421,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
46,278 | $2,806,760 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,327 | $2,136,123 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,421,862 | 21,116 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $23,108,846 | 21,503 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $15,987,902 | 20,954 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $16,225,916 | 20,815 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $17,425,049 | 21,098 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $16,073,040 | 20,820 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $18,581,705 | 20,974 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $19,376,942 | 21,402 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $16,849,835 | 21,659 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $12,648,198 | 21,698 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $12,000,021 | 22,341 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $10,444,184 | 22,270 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $7,692,264 | 22,399 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $8,339,322 | 22,795 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $5,236,653 | 16,195 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $6,574,087 | 20,276 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $5,782,096 | 20,191 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $5,600,636 | 20,276 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $4,754,084 | 20,576 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $4,756,802 | 20,725 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $3,930,505 | 21,039 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $4,539,600 | 26,887 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $4,174,608 | 28,203 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $4,776,488 | 29,093 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,340,964 | 31,293 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||